TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
2.69B
Market cap2.69B
Price-Earnings ratio
20.46
Price-Earnings ratio20.46
Dividend yield
—
Dividend yield—
Average volume
703.01K
Average volume703.01K
High today
$80.85
High today$80.85
Low today
$77.57
Low today$77.57
Open price
$79.77
Open price$79.77
Volume
489.26K
Volume489.26K
52 Week high
$156.00
52 Week high$156.00
52 Week low
$60.11
52 Week low$60.11

Stock Snapshot

As of today, TransMedics Group(TMDX) shares are valued at $77.58. The company's market cap stands at 2.69B, with a P/E ratio of 20.46.

On 2026-10-02, TransMedics Group(TMDX) stock moved within a range of $77.57 to $80.85. With shares now at $77.58, the stock is trading +0.0% above its intraday low and -4.0% below the session's peak.

Trading volume for TransMedics Group(TMDX) stock has reached 489.26K, versus its average volume of 703.01K.

Over the past 52 weeks, TransMedics Group(TMDX) stock has traded between a high of $156.00 and a low of $60.11.

Over the past 52 weeks, TransMedics Group(TMDX) stock has traded between a high of $156.00 and a low of $60.11.

TMDX News

Simply Wall St 1d
TransMedics Group, Why Is It Back In The Spotlight?

TransMedics Group (TMDX) is back on investor radar after director David Weill bought 1,336 shares on 11 September 2026, lifting his direct stake to 16,392 share...

TransMedics Group, Why Is It Back In The Spotlight?
Nasdaq 3d
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?

TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? Key Points The director acquired 1,336 shares for a total value of ~$1...

TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?

Analyst ratings

67%

of 12 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.